belinostat has been researched along with Brain-Neoplasms* in 1 studies
1 other study(ies) available for belinostat and Brain-Neoplasms
| Article | Year |
|---|---|
Discovery of HDAC6-Selective Inhibitor NN-390 with
Histone deacetylase 6 (HDAC6) has been targeted in clinical studies for anticancer effects due to its role in oncogenic transformation and metastasis. Through a second-generation structure-activity relationship (SAR) study, the design, and biological evaluation of the selective HDAC6 inhibitor Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; Models, Molecular; Molecular Docking Simulation; Neoplastic Stem Cells; Structure-Activity Relationship | 2022 |